MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-02-0072523
Alchymars Icm SM Private Limited - pharma in Alathur, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹13.88 Cr
▼ 36% YoY
Net loss · FY 2022
₹6.73 Cr
Net margin -48.5%
EBITDA · FY 2022
-₹4.17 Cr
EBITDA margin -30%
Authorised capital
₹11.2 Cr
Registered with MCA
Paid-up capital
₹10.45 Cr
Issued & subscribed
Open charges
₹1 Cr
Satisfied ₹38.67 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
91
Provident fund records
About Alchymars Icm SM Private Limited
Data last updated:
Alchymars Icm SM Private Limited is a private limited company based in Alathur, Tamil Nadu, India, a subsidiary of Genphar Pro Investments (Gb). It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 21 January 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U65991TN2000PTC043982. Its GSTIN is 33AAECS2214B1Z5 (Tamil Nadu).
The company has an authorised share capital of ₹11.2 Cr and a paid-up capital of ₹10.45 Cr. It was formerly known as Saimirra Finechem Private Limited. It is led by directors including Maurizio Silvestri and Riccardo Anzuini.
Its last annual general meeting (AGM) was held on 30 June 2025, and its latest financial statements are for the year ended 31 December 2024. The registered office is at A – 14 & 20 SIDCO Pharmaceutical Complex, Alathur, Tamil Nadu, India – 603110.
As per the financials filed for FY 2022, the company reported a revenue of ₹13.88 Cr, a decline of 36% compared to the previous year. For the same year it recorded a net loss of ₹6.73 Cr (net margin -48.5%) and EBITDA of -₹4.17 Cr (EBITDA margin -30%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years and 28% over five years.
The company has about 91 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1 Cr and satisfied charges of ₹38.67 Cr on record. Court records list 28 cases involving the company, including 14 filed by the company and 14 filed against it.
Alchymars Icm SM Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0072523). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aistrifarma.com.
Company details
CIN U65991TN2000PTC043982
Registration Number 043982
Incorporation Date 21 January 2000
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 June 2025
Date of Balance Sheet 31 December 2024
Parent Company Genphar Pro Investments (Gb)
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-02-0072523
Recognitions & Rankings of Alchymars Icm SM
Contact details
Alchymars Icm SM Private Limited's registered office is in Alathur, Tamil Nadu. Its website is aistrifarma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressA – 14 & 20 SIDCO Pharmaceutical Complex, Alathur, Tamil Nadu, India – 603110
- IndustryPharma, API Manufacturers
To see the full contact details of Alchymars Icm SM Private Limited, buy the company report.
Comprehensive company report
Alchymars Icm SM Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Alchymars Icm SM Private Limited
FY 2024 filings availableAlchymars Icm SM Private Limited reported revenue of ₹13.88 Cr (down 36% YoY) for FY 2022.
Revenue · FY 2022
₹13.88 Cr ▼ 36%
Net loss · FY 2022
₹6.73 Cr margin -48.5%
EBITDA · FY 2022
-₹4.17 Cr margin -30%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 36%
3 years · compounded
▼ 30%
5 years · compounded
▼ 28%
Revenue has declined at a compounded annual rate (CAGR) of 28% over five years, including a 36% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹13.88 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.17 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.73 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -30% | ||||
| Net Profit Margin | -48.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alchymars Icm SM Private Limited, buy the company report.
Board of directors of Alchymars Icm SM Private Limited
Alchymars Icm SM has 3 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maurizio Silvestri | Director | 26 Sep 2017 | 9 Years 0 Months | Current |
| Riccardo Anzuini | Director | 26 Sep 2017 | 9 Years 0 Months | Current |
| Kaliyamurthy Nagaradjan | Director | 08 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Alchymars Icm SM Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kekule Life Sciences Limited | ₹22.9 Cr (FY 2024) | 33.0% | Hyderabad, Telangana, India | |||
| Shakti Lifescience Private Limited | ₹21.77 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Ransh Pharma Private Limited | ₹21.75 Cr (FY 2025) | 27.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Ramis Laboratories Private Limited | ₹21.59 Cr (FY 2024) | 192.0% | Quthubullapur Hyderabad, Telangana, India | |||
| Avance Healthcare Private Limited | ₹21.12 Cr (FY 2025) | 19.0% | Rajkot, Gujarat, India | |||
| Vav Life Sciences Private Limited | ₹20.87 Cr (FY 2025) | -3.0% | Mumbai, Maharashtra, India | |||
| Norrish Laboratories Private Limited | ₹20.76 Cr (FY 2024) | 168.0% | Hyderabad, Telangana, India | |||
| Anphar Laboratories Private Limited | ₹20.75 Cr (FY 2025) | 27.0% | Jammu, Jammu and Kashmir, India | |||
| SBD Healthcare Private Limited | ₹20.74 Cr (FY 2024) | 92.0% | Ankleshwar, Gujarat, India | |||
| Alchymars Icm SM Private Limitedthis company | ₹13.88 Cr (FY 2022) | -₹6.73 Cr | -48.5% | -36.0% | 91 | Alathur, Tamil Nadu, India |
To see the full peer comparison of Alchymars Icm SM Private Limited, buy the company report.
Auditor
Alchymars Icm SM Private Limited is audited by K S JAGANNATHAN & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K S JAGANNATHAN & CO | FY 2022 | 001207S |
Shareholding
The shareholding of Alchymars Icm SM Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Alchymars Icm SM Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
₹38.67 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Apr 2022 | 100570283 | The Hongkong and Shanghai Banking Corporation Limited | ₹1 Cr | Open | |
| 14 Jan 2015 | 10545334 | Dbs Bank Ltd | ₹3 Cr | Satisfied | |
| 14 Jan 2015 | 10545336 | Dbs Bank Ltd | ₹4 Cr | Satisfied | |
| 21 Jan 2013 | 10399819 | The Hongkong and Shanghai Banking Corporation Limited | ₹5.55 Cr | Satisfied | |
| 24 Nov 2011 | 10323497 | Axis Bank Limited | ₹8.5 Cr | Satisfied |
To see the full charge records of Alchymars Icm SM Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Alchymars Icm SM Private Limited has 28 court cases on record: 14 filed by Alchymars Icm SM, 14 filed against it. All cases are disposed.
Total cases
28
Filed by the company
14
Filed against the company
14
Disposed
28
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 16 | 2 | 0 |
| District courts | 12 | 12 | 0 |
Cases on record (5 of 28)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed by the company against The State Tax Officer | Disposed |
| High Court, TAMIL NADU | Writ petition | Filed by the company against The State Tax Officer | Disposed |
| District court, Kancheepuram, Tamil Nadu | Court case (ID) | Filed against the company by an individual | Disposed |
| District court, Kancheepuram, Tamil Nadu | Court case (ID) | Filed against the company by an individual | Disposed |
| District court, Kancheepuram, Tamil Nadu | Court case (ID) | Filed against the company by an individual | Disposed |
To see the full case history of Alchymars Icm SM Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alchymars Icm SM Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Alchymars Icm SM Private Limited has a workforce of 91 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
91
Active EPFO establishments
1
Employee growth
7.06%
GST
Alchymars Icm SM has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAECS2214B1Z5 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Alchymars Icm SM Private Limited, buy the company report.
Recent activity
Alchymars Icm SM Private Limited has 17 board changes on record since 2016: 4 appointments and 13 cessations. The latest: Kaliyamurthy Nagaradjan ceased to be Additional Director on 29 Jun 2022.
AGM
Alchymars Icm Sm Private Limited last Annual general meeting of members was held on 30 Jun 2025 as per latest MCA records.
Filing
Alchymars Icm Sm Private Limited has filed its annual Financial statements for the year ended 31 Dec 2024 with Roc Chennai.
Charges
A charge registered on 21 Jan 2013 via Charge ID 10399819 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 19 Sep 2022.
Ceased
Kaliyamurthy Nagaradjan ceased to be Additional Director.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 1.00 Cr with Charge ID 100570283 was registered on 25 Apr 2022.
Ceased
Balkrishnan Suresh Babu ceased to be Director.
Appointed
Kaliyamurthy Nagaradjan was appointed as Director.
Ceased
Aldo Rucano ceased to be Director.
Appointed
Vishal Khandelwal was appointed as Company Secretary.
Ceased
Maurizio Silvestri ceased to be Additional Director.
Ceased
Paolo Daniele Siviero ceased to be Additional Director.
Ceased
Riccardo Anzuini ceased to be Additional Director.
29 earlier events are in the company report.
Frequently asked questions
Alchymars Icm SM is an active private limited company based in Alathur, Tamil Nadu, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 21 January 2000 (26+ years old) and is registered under CIN U65991TN2000PTC043982.
Alchymars Icm SM has 3 current directors:
- Maurizio Silvestri - Director
- Riccardo Anzuini - Director
- Kaliyamurthy Nagaradjan - Director
The latest financial statements of Alchymars Icm SM on record with the MCA are for the year ended 31 December 2024. Its last annual general meeting was held on 30 June 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Alchymars Icm SM is 33AAECS2214B1Z5, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Alchymars Icm SM is U65991TN2000PTC043982. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alchymars Icm SM has 28 court cases on record: 14 filed by the company and 14 filed against it. Most are in the high courts.
Alchymars Icm SM was incorporated on 21 January 2000, making it 26+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Alchymars Icm SM by revenue are Kekule Life Sciences Limited, Shakti Lifescience Private Limited, Ransh Pharma Private Limited, Ramis Laboratories Private Limited, Avance Healthcare Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kaliyamurthy Nagaradjan ceased to be Additional Director on 29 Jun 2022. Balkrishnan Suresh Babu ceased to be Director on 08 Oct 2021. Kaliyamurthy Nagaradjan was appointed as Director on 08 Oct 2021. Alchymars Icm SM has 17 board changes on record in total.
Yes, Alchymars Icm SM is registered as a small enterprise under Udyam registration (number: UDYAM-TN-02-0072523).
Alchymars Icm SM can be reached through the website aistrifarma.com. Its registered office is in Alathur, Tamil Nadu, India.